CTOR Citius Oncology, Inc.

Fundamentals / CIK 0001851484 / USD

Citius Oncology, Inc. reported $112.1M in total assets and a net loss of $46.06M through September 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTOR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2022 to 2025), reported in USD.

$5.00M$2.50M$0-$23.36MFY 2022 Net Income: $381K2022FY 2023 Net Income: -$12.70M2023FY 2023 Net Income: $2.42M2023FY 2024 Net Income: -$21.15M2024FY 2025 Net Income: -$24.76M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Dec 31 Sep 30 Dec 31
Research & Development $6.42M $4.93M -- $4.24M --
Total Operating Expenses $23.52M $20.57M -- $12.12M --
Operating Income -$23.52M -$20.57M -$1.01M -- -$138K
Interest Income $36K -- -- -- --
Interest Expense $218K -- -- -- --
Income Before Tax -$23.70M -$20.57M -- -$12.12M --
Income Tax Expense $1.06M $576K -- $576K --
Net Income -$24.76M -$21.15M $2.42M -$12.70M $381K
Basic EPS -$0.34 -$0.31 $0.27 -$0.19 $0.12
Diluted EPS -$0.34 -$0.31 $0.27 -$0.19 $0.12
Basic Shares Outstanding 73.3M 68.1M 6.6M 67.5M 1.3M
Diluted Shares Outstanding 73.3M 68.1M 6.6M 67.5M 1.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $1.49M $1.67M $3.94M -- -- -- -- --
Cost of Revenue $492K $329K $789K -- -- -- -- --
Gross Profit $1.00M $1.34M $3.15M -- -- -- -- --
Research & Development $218K $1.08M $1.02M $1.08M $938K $3.14M $1.26M $1.30M
Total Operating Expenses $9.72M $29.95M $8.41M $4.71M $4.94M $7.47M $6.39M $6.67M
Operating Income -$8.72M -$28.61M -$5.25M -$4.71M -$4.94M -$7.47M -$6.39M --
Interest Income $97K $44K $28K -- -- -- -- --
Interest Expense $232K $33K $46K -- $161K -- -- --
Income Before Tax -$9.03M -$26.84M -$5.27M -$4.73M -$5.11M -$7.47M -$6.39M -$6.67M
Income Tax Expense -$107K -$231K $264K $264K $264K $264K $264K $144K
Net Income -$8.92M -$26.61M -$5.53M -$5.00M -$5.37M -$7.74M -$6.66M -$6.81M
Basic EPS -$0.08 -$0.27 -$0.06 -- -$0.08 -$0.11 -$0.09 --
Diluted EPS -$0.08 -$0.27 -$0.06 -- -$0.08 -$0.11 -$0.09 --
Basic Shares Outstanding 107.9M 100.0M 87.5M -- 71.6M 71.6M 71.6M --
Diluted Shares Outstanding 107.9M 100.0M 87.5M -- 71.6M 71.6M 71.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Dec 31 Sep 30 Dec 31 Dec 31
Cash & Cash Equivalents $3.92M $112 $33K $27K $289K --
Cash & Short-Term Investments $3.92M $112 $33K $27K $289K --
Inventory $22.29M $8.27M -- -- -- --
Total Current Assets $27.54M $10.97M $58K $7.73M $377K $126K
Long-Term Investments -- -- $72.57M $70.63M $67.81M --
Total Non-Current Assets $73.40M $73.40M $72.57M $40.00M $67.81M $0
Total Assets $100.9M $84.37M $72.62M $47.73M $68.19M $126K
Accounts Payable $13.23M $3.71M -- $1.29M -- --
Total Current Liabilities $49.49M $32.70M $2.05M $21.05M $32K $137K
Total Non-Current Liabilities $6.59M $5.53M -- $1.15M $0 $0
Total Liabilities $56.08M $38.23M -- $22.20M $32K $137K
Common Stock $8.4K $7.2K $167 $6.8K $242 $173
Retained Earnings -$64.04M -$39.28M -$1.99M -$18.13M $345K -$10K
Total Stockholders' Equity $44.87M $46.14M $22.73M $25.54M $346K -$10K
Total Equity $44.87M $46.14M $22.73M $25.54M $346K -$10K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $16.56M $2.63M $7.30M $3.92M $112 $112 $112 $112
Cash & Short-Term Investments $16.56M $2.63M $7.30M $3.92M $112 $112 $112 $112
Accounts Receivable, Net $686K $1.08M $4.05M -- -- -- -- --
Inventory $22.63M $22.66M $22.64M $22.29M $17.21M $15.34M $14.38M $8.27M
Total Current Assets $42.71M $29.42M $37.15M $27.54M $18.31M $18.04M $17.08M $10.97M
Total Non-Current Assets $69.39M $71.28M $72.83M $73.40M $73.40M $73.40M $73.40M $73.40M
Total Assets $112.1M $100.7M $110.0M $100.9M $91.71M $91.44M $90.48M $84.37M
Accounts Payable $7.32M $8.88M $10.45M $13.23M $8.67M $7.68M $5.87M $3.71M
Total Current Liabilities $58.79M $58.81M $44.71M $49.49M $52.99M $49.74M $43.40M $32.70M
Total Non-Current Liabilities $12.92M $6.62M $6.85M $6.59M $6.32M $6.06M $5.79M $5.53M
Total Liabilities $71.71M $65.43M $51.56M $56.08M $59.31M $55.80M $49.19M $38.23M
Total Debt (incl. Leases) $6.41M -- -- -- -- -- -- --
Common Stock $11K $9.3K $8.5K $8.4K $7.2K $7.2K $7.2K $7.2K
Retained Earnings -$105.1M -$96.18M -$69.57M -$64.04M -$59.04M -$53.67M -$45.94M -$39.28M
Total Stockholders' Equity $40.38M $35.27M $58.41M $44.87M $32.40M $35.64M $41.29M $46.14M
Total Equity $40.38M $35.27M $58.41M $44.87M $32.40M $35.64M $41.29M $46.14M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Dec 31 Sep 30 Dec 31
Net Income -$24.76M -$21.15M $2.42M -$12.70M $381K
Stock-Based Compensation $8.32M $7.50M -- $1.97M --
Change in Inventory -$12.65M -$2.13M -- -- --
Change in Payables $9.52M $2.42M -- $1.20M --
Operating Cash Flow -$5.49M $126K -$601K -- -$48K
Investing Cash Flow -$5.75M -$5.00M -$1.32M -- -$67.32M
Common Stock Issued $15.17M -- -- -- $66.00M
Financing Cash Flow $15.17M $4.87M $1.66M -- $67.66M
Net Change in Cash $3.92M $112 -$256K -- $289K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$8.92M -$26.61M -$5.53M -$5.00M -$5.37M -$7.74M -$6.66M -$6.81M
Stock-Based Compensation $3.56M $3.53M $3.96M $2.30M $2.13M $2.09M $1.81M $1.67M
Change in Receivables $393K $2.97M -$4.05M -- -- -- -- --
Change in Inventory $34K -$20K -$353K -$3.71M -$1.87M -$958K -$6.11M --
Change in Payables -$1.57M -$1.56M -$2.79M $4.57M $991K $1.80M $2.16M $3.71M
Operating Cash Flow -$2.71M -$3.83M -$7.35M -- -- -- -- --
Investing Cash Flow -$2.00M -$600K -$4.40M -- -- -- -- --
Common Stock Issued -$818 -$62K $15.13M $15.17M -- -- -- --
Financing Cash Flow $18.64M -$231K $15.13M -- -- -- -- --
Net Change in Cash $13.93M -$4.66M $3.37M -- -- -- -- --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Dec 31 Sep 30 Dec 31
Return on Equity (ROE) -55.2% -45.8% 10.6% -49.7% 110.2%
Return on Assets (ROA) -24.5% -25.1% 3.3% -26.6% 0.6%
Current Ratio 0.56x 0.34x 0.03x 0.37x 11.85x
Quick Ratio 0.11x 0.08x 0.02x 0.00x 9.08x
Net Income Growth (YoY) -- -- +535.3% -- --
EPS Growth (YoY) -- -- +125.0% -- --
Operating Cash Flow Growth (YoY) -4446.6% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -114.1% -120.5% -40.5% -55.2% -82.0% -72.9% -55.9% -45.8%
Return on Assets (ROA) -41.1% -42.2% -21.5% -24.5% -29.0% -28.4% -25.5% -25.1%
Current Ratio 0.73x 0.50x 0.83x 0.56x 0.35x 0.36x 0.39x 0.34x
Quick Ratio 0.34x 0.12x 0.32x 0.11x 0.02x 0.05x 0.06x 0.08x
Debt to Equity 0.16x -- -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -- -- -4413.5%
Source: SEC EDGAR CompanyFacts (CIK 0001851484) · from June 30, 2021 Data through June 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal